vTv Therapeutics Inc.

NASDAQ:VTVT

13.87 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 001-0.00900.00900.00900.00920.00930.0090.9876.3990.00700.0080.0070.0081.8280.9214.5223.3752.4732.0640.2330.0150.0130.030.0380.0380.1820.3760.2260.1330.110.050.9340.40.2010.014
Cost of Revenue 00.0230.0220.0230.0220.0230.0220.0230.0240.0880.0230.0052.3822.4373.1032.5341.7682.5094.2044.4063.6634.2282.8222.82.6988.5948.94310.0688.9899.62310.9611.09911.16512.14911.3358.9467.1595.7027.7765.4624.3284.5354.404
Gross Profit 0-0.0230.978-0.032-0.022-0.014-0.022-0.014-0.024-0.0791.9770.0040.618-2.428-2.1163.865-1.761-2.509-4.196-4.399-3.655-2.4-1.9011.7220.677-6.121-6.879-9.835-8.974-9.61-10.93-11.061-11.127-11.967-10.959-8.72-7.026-5.592-7.726-4.528-3.928-4.334-4.39
Gross Profit Ratio 000.9783.5560-1.5560-1.5560-8.7780.9890.4450.206-269.778-2.1440.604-251.5710-524.5-628.429-456.875-1.313-2.0640.3810.201-2.475-3.333-42.21-598.267-739.231-364.333-291.079-292.816-65.753-29.146-38.584-52.827-50.836-154.52-4.848-9.82-21.562-313.571
Reseach & Development Expenses 3.2243.4392.6272.1152.8244.6913.9423.9643.0552.2053.1335.4022.3822.4373.1032.5341.7682.5094.2044.4063.6634.2282.8222.82.6988.5948.94310.0688.9899.62310.9611.09911.16512.14911.3358.9467.1595.7027.7765.4624.3284.5354.404
General & Administrative Expenses 3.2823.7163.9782.5692.5443.3093.4852.3882.6341.8315.3485.7162.2212.2422.1642.0351.0711.6952.451.9891.772.3922.3862.0732.1582.7372.2552.9372.5673.0052.8242.2522.4012.6722.5812.372.4152.2971.9952.141.5922.8585.127
Selling & Marketing Expenses 0000000000000000000000000000000000000000000
SG&A 3.2823.7163.9782.5692.5443.3093.4852.3882.6341.8315.3485.7162.2212.2422.1642.0351.0711.6952.451.9891.772.3922.3862.0732.1582.7372.2552.9372.5673.0052.8242.2522.4012.6722.5812.372.4152.2971.9952.141.5922.8585.127
Other Expenses 00-0.3710.185-3.2990.6381.5530.1070.079-0.114-2.7421.63200-1.648-0.1560.814-0.565-0.363-0.223-0.1460.2760.921-1.2480.3290.3160.011-0.19000-0.0240.0020.001-0.0010.031-0.381-1.6780.492-0.649-0.147-0.151-0.179
Operating Expenses 6.5067.1556.6054.6845.36887.4276.3525.6894.0368.48111.1184.6034.6795.2674.5692.8394.2046.6546.3955.4336.625.2084.8734.85611.33111.19813.00511.55612.62813.78413.35113.56614.82113.91611.3169.5747.9999.7717.6025.927.3939.531
Operating Income -6.506-7.155-5.627-4.707-6.654-8-7.427-6.343-5.689-4.027-6.481-11.109-1.603-4.67-4.281.83-2.832-4.204-6.646-6.388-5.425-4.792-4.287-0.351-1.481-8.858-9.134-12.772-11.541-12.615-13.754-13.313-13.528-14.639-13.54-11.09-9.441-7.889-9.721-6.668-5.52-7.192-9.517
Operating Income Ratio 00-5.6275230-888.8890-704.7780-447.444-3.241-1,234.333-0.534-518.889-4.3360.286-404.5710-830.75-912.571-678.125-2.621-4.655-0.078-0.439-3.582-4.425-54.815-769.4-970.385-458.467-350.342-356-80.434-36.011-49.071-70.985-71.718-194.42-7.139-13.8-35.781-679.786
Total Other Income Expenses Net 1.7230.746-0.2920.266-3.1720.7891.6530.2530.221-0.064-2.7431.6260.2383.829-1.647-0.2230.579-0.787-0.519-0.494-0.535-0.2220.305-1.977-0.48-0.538-0.826-1.02-0.814-0.799-0.532-0.3980.0230.0220.020.031-0.381-2.523-0.092-1.047-0.35-0.212-5.595
Income Before Tax -4.783-6.409-5.919-4.441-6.654-7.211-5.774-6.09-5.468-4.091-9.224-9.483-1.365-0.841-5.9271.607-2.253-4.991-7.165-6.882-5.96-5.014-3.982-2.328-1.961-9.396-9.96-13.792-12.355-13.414-14.286-13.711-13.505-14.617-13.52-11.059-9.822-10.412-9.813-7.715-5.87-7.404-15.112
Income Before Tax Ratio 00-5.919493.4440-801.2220-676.6670-454.556-4.612-1,053.667-0.455-93.444-6.0050.251-321.8570-895.625-983.143-745-2.743-4.324-0.515-0.581-3.799-4.826-59.193-823.667-1,031.846-476.2-360.816-355.395-80.313-35.957-48.934-73.85-94.655-196.26-8.26-14.675-36.836-1,079.429
Income Tax Expense 000.1-0.963-3.321-0.952-1.275-0.2-1.207-0.940.2-0.1150.1-0.2330.0150.370.329-1.966-2.636-2.438-2.1020.1-0.28-1.849-0.0140.2-6.1420.8-8.67-9.418-10.039-39.001-9.533-10.159-9.669-8.03-5.719-0.8331.076-0.3110.056-0.0955.233
Net Income -4.783-5.18-4.865-3.478-6.654-5.619-4.499-5.89-4.261-3.151-9.424-7.051-1.087-0.608-4.2411.126-1.533-3.368-4.724-4.399-3.608-2.882-2.155-1.091-0.796-3.072-2.952-4.311-3.65-3.963-4.22-4.05-3.993-4.457-3.852-3.169-4.103-10.412-9.813-7.715-5.87-7.404-15.112
Net Income Ratio 00-4.865386.4440-624.3330-654.4670-350.111-4.712-783.444-0.362-67.556-4.2970.176-2190-590.5-628.429-451-1.577-2.34-0.241-0.236-1.242-1.43-18.502-243.333-304.846-140.667-106.579-105.079-24.489-10.245-14.022-30.85-94.655-196.26-8.26-14.675-36.836-1,079.429
EPS -0.88-0.81-1.17-1.67-3.27-2.76-2.21-2.89-2.12-1.79-5.63-4.22-0.71-0.41-30.94-1.27-2.95-4.35-4.64-4.49-4.11-3.77-2.47-2.59-12.23-12.17-17.79-15.06-16.35-17.41-16.71-16.48-18.64-16.69-13.84-19.76-50.15-47.26-37.16-28.57-36.03-73.54
EPS Diluted -0.88-0.81-1.17-1.67-3.27-2.76-2.21-2.89-2.12-1.79-5.63-4.22-0.71-0.41-30.94-1.27-2.95-4.35-4.64-4.49-4.11-3.77-2.47-2.59-12.23-12.17-17.79-15.06-16.35-17.41-16.71-16.48-18.64-16.69-13.84-19.76-50.15-47.26-37.16-28.57-36.03-73.54
EBITDA -5.818-6.386-5.605-4.411-8.514-7.186-7.405-6.061-5.436-4.069-9.2-9.455-1.337-0.819-5.9041.852-1.995-4.747-6.97-6.584-5.548-4.492-3.348-1.478-1.109-8.487-9.063-12.895-11.458-12.53-13.675-13.268-13.437-14.57-13.461-10.95-9.327-7.775-9.096-7.194-5.439-7.132-9.463
EBITDA Ratio 00-5.605520.4440-798.4440-6760-452.111-4.6-1,053-0.527-516.444-5.9820.262-2850-871.25-942.714-694.5-2.457-3.635-0.351-0.329-3.432-4.391-55.536-763.867-963.846-455.833-350.447-354.211-79.934-35.747-49.071-70.985-85.936-181.92-7.638-13.598-35.458-675.643